Atossa Therapeutics Inc (ATOS)
$0.71
0.00 (0.00%)
ATOS Stock Quote Delayed 30 Minutes
The 3 Best Biotech Stocks Under $1 to Buy for January
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
11 Best Stocks to Buy for 2023
INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
89.52M
PE Ratio
-17.68
EPS
-0.04
Volume (Avg. Vol.)
1
Day's Range
-
52-Week Range
$0.50 - $1.39
Dividend & Yield
N/A (N/A)
ATOS Stock Predictions, Articles, and Atossa Therapeutics Inc News
Atossa Therapeutics Has a Steep Climb Ahead of It
Atossa Therapeutics is popular with the Reddit crowd. However, ATOS stock doesn’t make the top 25 on the platform. Should you buy it anyway?
As its Meme Status Has Come and Gone, Skip Out on Atossa Therapeutics Stock
So, overvalued, with low squeeze odds, what's the best move with ATOS stock? Sell or avoid, before dilution and other factors push it back down to its pre-hype price levels of around $1 per share.
Don’t Give In to Temptation in Atossa Therapeutics
Atossa Therapeutics has made a pivot to assist in the battle to fight Covid-19. But it seems that investors in ATOS stock are finding this to be a message they've already heard.
With Zero Revenue, I Can’t Get Excited About Atossa
ATOS stock surged briefly in 2021 based on several catalysts, but none of them right now is supportive of its current price and valuation.
The Bear Case for Atossa Therapeutics Makes More Sense at This Time
Investors have become wary of the risks surrounding Atossa's pipeline. That caution will continue pulling down ATOS stock
Investors Should Avoid High-Risk Atossa Therapeutics
Given the early stages of Atossa's clinical trials, ATOS stock is too risky to get involved with at this point.
ATOS Stock: The Big News That Has Atossa Therapeutics Plunging 20% Today
ATOS stock is on its way down today. As the biotech company announces a special shareholder meeting, holders worry about stock dilution.
Wait for Atossa Therapeutics Stock to Slide Further Before Buying
The potential with its breast cancer and Covid-19 treatment candidates notwithstanding, don't fight the trend with ATOS stock.
Atossa Therapeutics Might Shoot Up Quickly on Covid-19 Fear
ATOS stock is a relatively unknown pharmaceutical firm that is worth keeping an eye on due to surging Covid-19 cases.
Think Carefully Before Speculating on Atossa Therapeutics
ATOS stock attracted social media for its possible short-squeeze play and its therapeutic offerings but speculators should be careful.
A Promising Covid-19 Treatment Makes Atossa Therapeutics Intriguing
Traders will continue to analyze the short-squeeze potential of ATOS stock, but investors should also focus on Atossa's clinical progress.
The Bulls Are in Charge of Atossa Therapeutics
The Reddit crowd might decide to target ATOS stock for a short squeeze, but that's not the only reason to take a long position today.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! We're taking a look at the biggest pre-market stock movers for Wednesday and that includes the winners and losers.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning! Let's get ready for trading to start off strong this week with a look at the biggest pre-market stock movers for Monday!
ATOS Stock: How Redditors and a June 28 Catalyst Are Squeezing Atossa Therapeutics
Today, ATOS stock is on the move as a range of catalysts appear to be lining up perfectly for retail investors in this Reddit favorite.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Welcome back, investors! We're at it again with another look at the biggest pre-market stock movers for Thursday morning.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? Investors scrutinized updates to the Colonial Pipeline saga and bet on meme stocks.
ATOS Stock: What Is the Big Catalyst for Atossa Therapeutics on June 9?
Today, ATOS stock is taking off on the veiled announcement of the release of some Phase 2 study data for one of the company's leading drugs.
